SAVANNAH, GEORGIA – The investigational monoclonal antibody nipocalimab (Johnson & Johnson) is associated with significant improvement in patients with generalized myasthenia gravis (gMG) over a 24-week […]

Sleep patterns, physical activity, mood, and heart rate can affect brain connectivity in the short and longer term, results of a unique precision brain mapping study […]

Older adults at risk for dementia can be identified using mobile data obtained during a wayfinding task, a novel real-world study suggested. During a smartphone-assisted scavenger […]

PHILADELPHIA — Early adjuvant use of opicapone (Ongentys) may reduce the risk for complications in patients with early Parkinson’s disease (PD) and no motor complications. The […]

PHILADELPHIA — The experimental vaccine UB-312 shows early promise in Parkinson’s disease (PD) and multiple system atrophy (MSA), results of a phase 1b study suggest. “UB-312 […]

A first stroke in older adults is associated with substantial immediate and accelerated long-term cognitive decline, suggested a new study that underscores the need for continuous […]

Enzyme-inducing antiseizure medications (EIASMs) increase the risk for new-onset cardiovascular events among older adults with epilepsy, a new study suggests. In a prospective cohort study of […]

PHILADELPHIA — Tavapadon, an experimental first-in-class oral selective partial D1/D5 dopamine receptor agonist for Parkinson’s disease (PD), was shown to significantly reduce disease burden in two […]